{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:11:03Z","timestamp":1778829063439,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":204,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007924","name":"Bengbu Medical College","doi-asserted-by":"publisher","award":["2020byzd149"],"award-info":[{"award-number":["2020byzd149"]}],"id":[{"id":"10.13039\/501100007924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clinsp.2024.100469","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T08:27:29Z","timestamp":1722673649000},"page":"100469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The relationship of C-Reactive Protein to Albumin Ratio and interval debulking surgery outcome after neoadjuvant chemotherapy in ovarian cancer patients"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5060-2199","authenticated-orcid":false,"given":"Yi","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3819-7820","authenticated-orcid":false,"given":"Shuyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4157-7316","authenticated-orcid":false,"given":"Mengran","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0599-6999","authenticated-orcid":false,"given":"Caizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0403-9054","authenticated-orcid":false,"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clinsp.2024.100469_bib0001","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3390\/cancers14092230","article-title":"On behalf of Ncd Global Health Research Group Of Association Of Pacific Rim Universities Apru. worldwide burden, risk factors, and temporal trends of ovarian cancer: A Global Study","volume":"14","author":"Huang","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100469_bib0002","first-page":"561","article-title":"Ovarian cancer: an overview","volume":"91","author":"Penny","year":"2020","journal-title":"Radiol Technol"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100469_bib0003","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","article-title":"Ovarian cancer: an integrated review","volume":"35","author":"Stewart","year":"2019","journal-title":"Semin Oncol Nurs"},{"issue":"4","key":"10.1016\/j.clinsp.2024.100469_bib0004","doi-asserted-by":"crossref","first-page":"330","DOI":"10.23736\/S0026-4806.19.06078-6","article-title":"Primary debulking surgery vs. interval debulking surgery for advanced ovarian cancer: review of the literature and meta-analysis","volume":"110","author":"Chiofalo","year":"2019","journal-title":"Minerva Med"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100469_bib0005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/14737140.2018.1458614","article-title":"The role of neoadjuvant chemotherapy in ovarian cancer","volume":"18","author":"Elies","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.clinsp.2024.100469_bib0006","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cca.2018.04.030","article-title":"Serum CA125 levels predict outcome of interval debulking surgery after neoadjuvant chemotherapy in patients with advanced ovarian cancer","volume":"484","author":"Zhang","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"8","key":"10.1016\/j.clinsp.2024.100469_bib0007","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/cancers10080251","article-title":"The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer","volume":"10","author":"Savant","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clinsp.2024.100469_bib0008","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejcsup.2019.12.002","article-title":"Inflammation and immunity in ovarian cancer","volume":"15","author":"Salas-Benito","year":"2020","journal-title":"EJC Suppl"},{"issue":"11","key":"10.1016\/j.clinsp.2024.100469_bib0009","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.7150\/jca.15401","article-title":"Exploration and Validation of C-Reactive Protein\/Albumin Ratio as a Novel Inflammation-Based Prognostic Marker in Nasopharyngeal Carcinoma","volume":"7","author":"Zhang","year":"2016","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100469_bib0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12885-017-3220-x","article-title":"The prognostic value of the preoperative c-reactive protein\/albumin ratio in ovarian cancer","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.clinsp.2024.100469_bib0011","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2014.09.005","article-title":"CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy","volume":"135","author":"Pelissier","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.clinsp.2024.100469_bib0012","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1272\/jnms.84.170","article-title":"Serum CA 125 Level after Neoadjuvant Chemotherapy is Predictive of Prognosis and Debulking Surgery Outcomes in Advanced Epithelial Ovarian Cancer","volume":"84","author":"Matsuhashi","year":"2017","journal-title":"J Nippon Med Sch"},{"issue":"4","key":"10.1016\/j.clinsp.2024.100469_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2020.100536","article-title":"The role of changes in systemic inflammatory response markers during neoadjuvant chemotherapy in predicting suboptimal surgery in ovarian cancer","volume":"44","author":"G\u00fclseren","year":"2020","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.clinsp.2024.100469_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2023.100204","article-title":"Preliminary outcomes of five-year survival for ovarian malignancies in profiled Serbian Oncology Centre","volume":"78","author":"Gutic","year":"2023","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.clinsp.2024.100469_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2021.103112","article-title":"DNA damage response and PD-1\/PD-L1 pathway in ovarian cancer","volume":"102","author":"Zhang","year":"2021","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.clinsp.2024.100469_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2023.100177","article-title":"Programmed cell death-1 and its ligands: Current knowledge and possibilities in immunotherapy","volume":"78","author":"Gutic","year":"2023","journal-title":"Clinics (Sao Paulo)"},{"issue":"7","key":"10.1016\/j.clinsp.2024.100469_bib0017","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3390\/diagnostics11071298","article-title":"Decrease in neutrophil-to-lymphocyte ratio during neoadjuvant chemotherapy as a predictive and prognostic marker in advanced ovarian cancer","volume":"11","author":"Sanna","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100469_bib0018","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5937\/jomb0-26452","article-title":"Effects of adiponectin, plasma D-dimer, inflammation and tumor markers on clinical characteristics and prognosis of patients with ovarian cancer","volume":"41","author":"Li","year":"2022","journal-title":"J Med Biochem"},{"issue":"10","key":"10.1016\/j.clinsp.2024.100469_bib0019","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.21037\/gs-22-459","article-title":"Predictive value of the systemic immune-inflammation index for the efficacy of neoadjuvant chemotherapy and prognosis in patients with stage III ovarian cancer-a retrospective cohort study","volume":"11","author":"Wang","year":"2022","journal-title":"Gland Surg"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100469_bib0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ygyno.2018.11.034","article-title":"Systemic immune-inflammation index predicts prognosis in patients with epithelial ovarian cancer: A retrospective study","volume":"152","author":"Nie","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100469_bib0021","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13048-021-00902-0","article-title":"Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy","volume":"14","author":"Liontos","year":"2021","journal-title":"J Ovarian Res"},{"issue":"5","key":"10.1016\/j.clinsp.2024.100469_bib0022","doi-asserted-by":"crossref","first-page":"e12917","DOI":"10.1111\/eci.12917","article-title":"Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: a meta-analysis","volume":"48","author":"Tian","year":"2018","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100469_bib0023","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1080\/01635581.2021.1980591","article-title":"Prognostic value of pretreatment glasgow prognostic score\/modified glasgow prognostic score in ovarian cancer: a systematic review and meta-analysis","volume":"74","author":"Xu","year":"2022","journal-title":"Nutr Cancer"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100469_bib0024","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12957-021-02253-y","article-title":"Prognostic value of the C-reactive protein to albumin ratio in colorectal cancer: an updated systematic review and meta-analysis","volume":"19","author":"Liao","year":"2021","journal-title":"World J Surg Oncol"},{"issue":"5","key":"10.1016\/j.clinsp.2024.100469_bib0025","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00404-017-4511-9","article-title":"The preoperative albumin level is an independent prognostic factor for optimally debulked epithelial ovarian cancer","volume":"296","author":"Ayhan","year":"2017","journal-title":"Arch Gynecol Obstet"},{"issue":"4b","key":"10.1016\/j.clinsp.2024.100469_bib0026","first-page":"2941","article-title":"Malnutrition and cachexia in ovarian cancer patients: pathophysiology and management","volume":"21","author":"Gadducci","year":"2001","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1016\/j.clinsp.2024.100469_bib0027","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1080\/01635581.2020.1798479","article-title":"Significance of pretreatment C-reactive protein, albumin, and C-reactive protein to albumin ratio in predicting poor prognosis in epithelial ovarian cancer patients","volume":"73","author":"Komura","year":"2021","journal-title":"Nutr Cancer"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593224001467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593224001467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:37:46Z","timestamp":1778827066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593224001467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":27,"alternative-id":["S1807593224001467"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2024.100469","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship of C-Reactive Protein to Albumin Ratio and interval debulking surgery outcome after neoadjuvant chemotherapy in ovarian cancer patients","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2024.100469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100469"}}